GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells via Autophagy and Death Receptor Signaling
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells via Autophagy and Death Receptor Signaling
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-02
DOI
10.3389/fonc.2020.01331
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cholesterol derivatives induce dephosphorylation of the histone deacetylases Rpd3/HDAC1 to upregulate autophagy
- (2020) Wenmei Wu et al. Autophagy
- Combination therapy with Olaratumab/doxorubicin in advanced or metastatic soft tissue sarcoma -a single-Centre experience
- (2020) Jana Käthe Striefler et al. BMC CANCER
- GZ17‐6.02 initiates DNA damage causing autophagosome‐dependent HDAC degradation resulting in enhanced anti‐PD1 checkpoint inhibitory antibody efficacy
- (2020) Laurence Booth et al. JOURNAL OF CELLULAR PHYSIOLOGY
- (Curcumin+sildenafil) enhances the efficacy of 5FU and anti‐PD1 therapies in vivo
- (2020) Paul Dent et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Super-enhancers: novel target for pancreatic ductal adenocarcinoma
- (2019) Chandrayee Ghosh et al. Oncotarget
- Basic Knowledge in Soft Tissue Sarcoma
- (2019) Kévin Bourcier et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- A pilot study of first-line olaratumab, doxorubicin and ifosfamide in patients with metastatic soft tissue sarcoma
- (2019) Olga Vornicova et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib
- (2019) Christopher P Wilding et al. Expert Review of Anticancer Therapy
- Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds
- (2018) Vikalp Vishwakarma et al. Scientific Reports
- Curcumin interacts with sildenafil to kill GI tumor cells via endoplasmic reticulum stress and reactive oxygen/ nitrogen species
- (2017) Jane L. Roberts et al. Oncotarget
- HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody in vivo
- (2017) Laurence Booth et al. Oncotarget
- The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo
- (2017) Laurence Booth et al. Oncotarget
- AMPK/Snf1 signaling regulates histone acetylation: Impact on gene expression and epigenetic functions
- (2016) Antero Salminen et al. CELLULAR SIGNALLING
- Multi-kinase inhibitors can associate with heat shock proteins through their NH2-termini by which they suppress chaperone function
- (2016) Laurence Booth et al. Oncotarget
- The afatinib resistance of in vivo generated H1975 lung cancer cell clones is mediated by SRC/ERBB3/c-KIT/c-MET compensatory survival signaling
- (2016) Laurence Booth et al. Oncotarget
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pazopanib and HDAC inhibitors interact to kill sarcoma cells
- (2014) Seyedmehrad Tavallai et al. CANCER BIOLOGY & THERAPY
- The beta-carboline alkaloid harmine inhibits BCRP and can reverse resistance to the anticancer drugs mitoxantrone and camptothecin in breast cancer cells
- (2009) Yonggang Ma et al. PHYTOTHERAPY RESEARCH
- AMP-Activated Protein Kinase Regulates GLUT4 Transcription by Phosphorylating Histone Deacetylase 5
- (2008) S. L. McGee et al. DIABETES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started